Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F, Guggino G. Schinocca C, et al. Among authors: fasano s. Front Immunol. 2021 Feb 22;12:637829. doi: 10.3389/fimmu.2021.637829. eCollection 2021. Front Immunol. 2021. PMID: 33692806 Free PMC article. Review.
ILC3 in Axial Spondyloarthritis: the Gut Angle.
Mauro D, Macaluso F, Fasano S, Alessandro R, Ciccia F. Mauro D, et al. Among authors: fasano s. Curr Rheumatol Rep. 2019 Jun 13;21(7):37. doi: 10.1007/s11926-019-0834-9. Curr Rheumatol Rep. 2019. PMID: 31197599 Review.
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes.
Fasano S, Mauro D, Macaluso F, Xiao F, Zhao Y, Lu L, Guggino G, Ciccia F. Fasano S, et al. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):315-323. Epub 2020 Oct 23. Clin Exp Rheumatol. 2020. PMID: 33095148 Free article. Review.
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.
Restivo V, Candiloro S, Daidone M, Norrito R, Cataldi M, Minutolo G, Caracci F, Fasano S, Ciccia F, Casuccio A, Tuttolomondo A. Restivo V, et al. Among authors: fasano s. Autoimmun Rev. 2022 Jan;21(1):102925. doi: 10.1016/j.autrev.2021.102925. Epub 2021 Aug 26. Autoimmun Rev. 2022. PMID: 34454117 Review.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
Gatto M, Saccon F, Andreoli L, Bartoloni E, Benvenuti F, Bortoluzzi A, Bozzolo E, Brunetta E, Canti V, Cardinaletti P, Ceccarelli F, Ciccia F, Conti F, De Marchi G, de Paulis A, De Vita S, Emmi G, Faggioli P, Fasano S, Fredi M, Gabrielli A, Gasparotto M, Gerli R, Gerosa M, Govoni M, Gremese E, Laria A, Larosa M, Mosca M, Orsolini G, Pazzola G, Petricca L, Ramirez GA, Regola F, Rossi FW, Rossini M, Salvarani C, Scarpato S, Tani C, Tincani A, Ubiali T, Urban ML, Zen M, Doria A, Iaccarino L. Gatto M, et al. Among authors: fasano s. J Autoimmun. 2021 Nov;124:102729. doi: 10.1016/j.jaut.2021.102729. Epub 2021 Sep 30. J Autoimmun. 2021. PMID: 34600347
203 results